-+ 0.00%
-+ 0.00%
-+ 0.00%

Rothschild & Co Initiates Coverage On Guardant Health with Buy Rating, Announces Price Target of $203

Benzinga·09/08/2026 12:16:57
语音播报
Rothschild & Co analyst Jamie Clark initiates coverage on Guardant Health (NASDAQ:GH) with a Buy rating and announces Price Target of $203.